The Potential Role of Cytokine‐Mediated Vascular Endothelial Activation in the Pathogenesis of Kawasaki Disease
- 1 December 1991
- journal article
- review article
- Published by Wiley in Pediatrics International
- Vol. 33 (6) , 739-744
- https://doi.org/10.1111/j.1442-200x.1991.tb02602.x
Abstract
Kawasaki disease (KD) is an acute febrile illness of infancy and early childhood characterized by diffuse vasculitis. Although the disease is generally self-limited, up to 30% of untreated patients with KD may develop coronary artery (CA) abnormalities. The acute phase of KD is characterized by marked activation of the immune system leading to increased cytokine production by immune effector cells, the induction of activation antigens on their vascular endothelium and the generation of lytic antibodies directed against vascular endothelial cells (EC) stimulated with cytokines. Treatment with intravenous gammaglobulin (IVGG) usually rapidly reduces acute clinical symptoms and prevents CA abnormalities. Immunologically, successful IVGG treatment is associated with decreased lymphocyte activation, reduced cytokine secretion and the loss of cytokine induced expression of leukocyte adhesion molecules on vascular endothelium. The association between improvement of clinical symptoms with the reduction of cytokine secretion, and reversal of EC activation supports a role for immune mediated injury to cytokine induced EC antigens in the pathogenesis of this disorder.Keywords
This publication has 32 references indexed in Scilit:
- Serum-soluble interleukin-2 receptor levels in Kawasaki diseaseThe Journal of Pediatrics, 1990
- Spontaneous tumor necrosis factor production in Kawasaki diseaseThe Journal of Pediatrics, 1989
- Circulating Interleukin-1β in Patients with Kawasaki DiseaseNew England Journal of Medicine, 1988
- Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki diseaseClinical Immunology and Immunopathology, 1988
- Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapyThe Journal of Pediatrics, 1988
- High-dose gammaglobulin therapy for Kawasaki diseaseThe Journal of Pediatrics, 1987
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986
- Myocardial infarction in Kawasaki disease: Clinical analyses in 195 casesThe Journal of Pediatrics, 1986
- Kawasaki disease: Review of risk factors for coronary aneurysmsThe Journal of Pediatrics, 1986
- Immunoregulatory abnormalities in mucocutaneous lymph node syndromeClinical Immunology and Immunopathology, 1982